| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics, Inc. | Director | Common Stock, par value $0.00001 per share | 9.5K | $755K | $79.50 | Oct 25, 2024 | Direct |
| Viking Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | Oct 25, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | Oct 25, 2024 | 3 | -$1.2M | 4 | Oct 25, 2024 | Director |
| VKTX | Viking Therapeutics, Inc. | Sep 20, 2024 | 3 | -$704K | 4 | Sep 20, 2024 | Director |
| VKTX | Viking Therapeutics, Inc. | Aug 21, 2024 | 3 | -$391K | 4 | Aug 22, 2024 | Director |
| VKTX | Viking Therapeutics, Inc. | Aug 19, 2024 | 8 | -$942K | 4 | Aug 19, 2024 | Director |
| VKTX | Viking Therapeutics, Inc. | Aug 14, 2024 | 4 | -$1.03M | 4 | Aug 14, 2024 | Director |
| VKTX | Viking Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| VKTX | Viking Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| VKTX | Viking Therapeutics, Inc. | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |